Reengineering neurotechnology: placing patients first

Abstract

Neurotechnologies that measure and modulate brain activity have not yet reached widespread clinical relevance. To accelerate translation into patient care, we propose three strategic adjustments in neurotechnology research — to consider the scope, scalability and stakeholders.